Masatsugu Ueda
Comptroller/Controller/Auditor presso PHOENIXBIO CO., LTD.
Posizioni attive di Masatsugu Ueda
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PHOENIXBIO CO., LTD. | Comptroller/Controller/Auditor | 01/06/2019 | - |
Storia della carriera di Masatsugu Ueda
Precedenti posizioni note di Masatsugu Ueda
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - | - |
| PHOENIXBIO CO., LTD. | Direttore/Membro del Consiglio | 01/01/2007 | - |
| Corporate Officer/Principal | 01/01/2007 | - |
Statistiche
Distribuzione geografica
| Giappone | 3 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Comptroller/Controller/Auditor | 1 |
Settori
| Commercial Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHOENIXBIO CO., LTD. | Commercial Services |
| Aziende private | 1 |
|---|---|
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Masatsugu Ueda
- Esperienza
